Finance News
Complete Finance & Business News Journal

Covid-19 vaccine approval could stall tech stocks boom: Goldman


Approvals for a possible Covid-19 vaccine later this coming year could threaten the new surge in speculative expenditure in big U.T. technology companies and yank investors back towards some growth-linked cyclical stocks, as per analysts at Goldman Sachs.

Seen as “stay-at-home” winning trades in the coronavirus lockdowns, gives you in Apple Incorporation, Facebook Inc, and Buchstabenfolge have surged this year and today account for nearly a 6th of the S&P 500’s stock market value.

Bumper results from the iPhone maker a week ago pushed it past Saudi Aramco to become the tallest 3g base station most valuable publicly listed organization and heading towards a new $2 trillion valuation.

In a global markets research take note sent to clients, Goldman industry experts said the current rally could last until Labor Day time in early September, but will be threatened by updates upon vaccines.

“Approval could … immediate the kind of rotation that started out and petered out in May possibly and early June, promoting traditional cyclicals, steeper turns and banks, and tough tech leadership,” many people argued.

Get real time updates directly on you device, subscribe now.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Translate »